In Brief: Okla. Plan B restriction blocked; CRN knocks disease claims via NAD; Facebook testimonial stings Vibrant Life
This article was originally published in The Tan Sheet
Oklahoma judge blocks Plan B restrictions; CRN challenges disease claims via NAD; Lonza backs Alomune claims, ERSP says; Facebook testimonial prompts Vibrant Life warning; Rx adulterant recalls, alerts; and Codex adopts 11 nutrient reference values;.
You may also be interested in...
Several drug companies may have shuttered their Facebook pages prematurely in August after the social networking site revoked their exclusive privilege to block consumer comments on their walls.
Dietary supplement firms soon could export products internationally without having to reformulate to accommodate local nutrient value regulations.
A selective androgen receptor modulator also being studied in metastatic breast cancer, enobosarm might offer potential as add-on therapy to GLP-1 agonists prescribed for weight loss, the Miami biotech asserts.